PARODI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 3.531
EU - Europa 1.962
AS - Asia 1.311
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 4
AN - Antartide 2
Totale 6.851
Nazione #
US - Stati Uniti d'America 3.511
UA - Ucraina 1.269
CN - Cina 1.027
DE - Germania 415
SG - Singapore 190
IT - Italia 109
FR - Francia 48
SE - Svezia 47
TR - Turchia 38
AU - Australia 22
KR - Corea 22
GB - Regno Unito 20
CA - Canada 19
EU - Europa 18
BE - Belgio 8
IN - India 7
RU - Federazione Russa 7
JP - Giappone 5
PL - Polonia 5
AT - Austria 4
HU - Ungheria 4
CH - Svizzera 3
FI - Finlandia 3
HK - Hong Kong 3
LU - Lussemburgo 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
BG - Bulgaria 2
BR - Brasile 2
ES - Italia 2
GS - Georgia del Sud e Isole Sandwich Australi 2
IE - Irlanda 2
LA - Repubblica Popolare Democratica del Laos 2
NL - Olanda 2
PK - Pakistan 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CY - Cipro 1
EC - Ecuador 1
HR - Croazia 1
ID - Indonesia 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
MS - Montserrat 1
PE - Perù 1
Totale 6.851
Città #
Chandler 839
Jacksonville 717
Dearborn 515
Princeton 410
Nanjing 319
Wilmington 156
Singapore 116
Nanchang 100
Shenyang 87
Beijing 80
Jiaxing 65
Tianjin 61
Changsha 58
Hebei 53
Jinan 38
Izmir 32
Zhengzhou 30
Norwalk 27
Boardman 25
San Francisco 25
Kunming 24
Taizhou 23
Hangzhou 22
Seoul 22
Ann Arbor 21
Sassari 21
Toronto 16
Guangzhou 15
Ashburn 14
Ningbo 14
Woodbridge 13
Changchun 11
Canberra 9
Brussels 8
Melbourne 8
Edinburgh 7
Falls Church 7
Hefei 7
New York 7
Berlin 6
Mountain View 6
Los Angeles 5
Bergamo 4
Brescia 4
Lanzhou 4
London 4
Sydney 4
Tokyo 4
Aosta 3
Budapest 3
Cagliari 3
Central 3
Chicago 3
Frankfurt am Main 3
Helsinki 3
Innsbruck 3
Luxembourg 3
Napoli 3
Paris 3
Riyadh 3
San Giovanni Suèrgiu 3
Seattle 3
Shaoxing 3
Turin 3
Warsaw 3
Amsterdam 2
Bangkok 2
Belgrade 2
Bosisio Parini 2
Boston 2
Houston 2
Hyderabad 2
Markham 2
Milan 2
Reston 2
Rome 2
Sofia 2
Cernusco sul Naviglio 1
Chelyabinsk 1
Chengdu 1
Cleveland 1
Colombo 1
Denver 1
Dolianova 1
Dubai 1
Dubendorf 1
Escolca 1
Florence 1
Fuzhou 1
Gatchina 1
Gioia Del Colle 1
Gonnosfanàdiga 1
Goodland 1
Guasila 1
Hanover 1
Hitchcock 1
Horia 1
Islamabad 1
Islington 1
Istanbul 1
Totale 4.161
Nome #
Hemoglobin trajectories and blood transfusions associated with percutaneous left atrial appendage occlusion 71
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity. 66
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 53
Anxiety trait in patients with stress-induced cardiomyopathy: a case-control study 52
Balloon angioplasty of the radial artery to solve a challenging radial sheath insertion. 52
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity. 50
Cardiac abnormalities in Alzheimer Disease. Clinical relevance beyond pathophysiological rationale and instrumental findings? 49
Sudden floating thrombus formation on the delivery cable before Amplatzer-Amulet device deployment during left atrial appendage occlusion: The need for a standardized anticoagulation. 49
Understanding the complex interplay between coronary artery disease and Takotsubo syndrome: not all swans are white. 49
APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practice 49
Trying to catch the octopus in the trap: Takotsubo syndrome natural history. 48
Optimal antiplatelet therapy after an acute coronary syndrome in the elderly: An old issue. 48
Traumatic mitral valve regurgitation: a case report and state-of-the-art review 48
Atrial fibrillation in athletes: from epidemiology to treatment in the novel oral anticoagulants era 47
. Predictor of Stent Thrombosis in Patients Treated with Turbostratic Carbon-Coated Stent Implantation for Acute Myocardial Infarction 46
2017 Update on dual antiplatelet therapy: what's new? 46
Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction 46
Clinical implication of early mitral regurgitation in patients with reperfused acute myocardial infarction 46
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial 45
Secondary Takotsubo syndrome with severely reduced left ventricular ejection fraction: a warning for clinicians 45
Takotsubo syndrome in Heart Failure and World Congress on Acute Heart Failure 2019: highlights from the experts. 45
Inflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndrome. 45
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement. 45
Percutaneous Intervention for concurrent chronic total occlusions in patients with STEMI: We should EXPLORE more! 45
Chest pain relief in patients with acute myocardial infarction. 45
Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnostics. 44
Bleeding events and maintenance dose of prasugrel: BLESS pilot study. 44
Predictors of outcome after sirolimus eluting stent implantation for complex in-stent restenosis 43
Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation paclitaxel-eluting stents for unprotected left main disease 43
Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study. 43
Five-year outcome after primary coronary intervention for acute ST elevation myocardial infarction: Results from a single centre experience 43
Significance of additional ST segment elevation in patients with no reflow after angioplasty for acute myocardial infarction 43
Usefulness of the 64-slice multi-detector computed tomography for detecting drug eluting in-stent restenosis 43
Beneficial effects of listening to classical music in patients with heart failure: a randomized controlled trial. 43
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: A meta-regression analysis of 30 randomized trials. 42
The short-term prognostic role of chronic kidney disease in Takotsubo syndrome: Does it really matter? 42
Abnormal response to mental stress in patients with Takotsubo cardiomyopathy detected by gated single photon emission computed tomography 42
Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications 42
Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial 42
Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival. A prospective multicenter randomised trial comparing infarct artery stenting plus abciximab with stenting alone 42
Coronary Guidewire Fracture Into a Radial Artery Loop: A New Complication in the Transradial Era? 41
Distal embolic protection device transit through a left internal mammary artery for safely treating a saphenous vein graft anastomosed at a Y-configuration. 41
Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry. 41
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials. 41
Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. 41
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations. 40
Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms 40
Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. 40
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 40
Time corse of serum collagen typer I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension 40
Conservative Management and 1-Year Follow-Up of a Huge Left Atrial Intramural Hematoma Related to an Epicardial Collateral Perforation During a Chronic Total Occlusion Percutaneous Coronary Intervention 40
Does gender affect the clinical outcome of patients with acute myocardial infarction complicated by cardiogenic shock who undergo percutaneous coronary intervention 40
Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with the degree of hypertrophy 40
Long-term follow-up (4 years) of unprotected left main coronary artery disease treated with paclitaxel eluting stent (from the TRUE Registry) 40
Ticagrelor Crushed Tablets Administration in STEMI patients: The Mashed Or Just Integral Tablets of ticagrelOr (MOJITO) study 39
Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention 39
Takotsubo cardiomyopathy: a consensus document. 39
Cangrelor-supported primary percutaneous coronary intervention in a patient with cardiogenic shock due to left main acute occlusion 39
Aspirin Adherence in Subjects With glucose-6-phosphate-dehydrogenase Deficiency Having an Acute Coronary Syndrome 39
Efficacy and safety of alternative oral administrations of P2Y12-receptor inhibitors: Systematic review and meta-analysis. 39
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis) 39
Prognostic relevance of GRACE risk score in Takotsubo syndrome 39
Dual antiplatelet therapy in patients with acute coronary syndrome during coronavirus disease of 2019 pandemia: the right choice at right time. 39
Impact on Left Ventricular Function and Remodeling and on 1-Year Outcome in Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. 39
Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion 38
Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study 38
Epidemiology of Tako-tsubo cardiomyopathy: the Tuscany Registry for Tako-tsubo Cardiomyopathy 38
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty. 38
Comorbidities Frequency in Takotsubo Syndrome: An International Collaborative Systematic Review Including 1,109 Patients. 38
Comparison of the usefulness of Doppler-derived deceleration time versus plasma brain natriuretic peptide to predict left ventricular remodelling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction 38
High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease 38
Routine percutaneous coronary intervention in elderly patients with cardiogenic shock complicating acute myocardial infarction 37
Prevalence, predictors, time course and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction 37
Left ventricular apical ballooning syndrome as a novel cause of acute mitral regurgitation 37
New Technologies in coronary interventional cardiology: results from the first inter-regional survey promoted by SICI-GISE in four regions of northern Italy ("the GISE TOLOVE" area: Tuscany, Lombardy, Veneto, Emilia-Romagna 37
Independent Impact of RV Involvement on In-Hospital Outcome of Patients With Takotsubo Syndrome. 37
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19 37
Predictors of thromboembolic events in Takotsubo syndrome 36
[Coronary wire entrapment and unintended extraction of a just deployed stent] 36
Late coronary stent thrombosis associated with exercise testing. 36
Preprocedural TIMI flow and infarct size in STEMI undergoing primary angioplasty. 36
Comparison of Double (360 mg) Ticagrelor Loading Dose with Standard (60 mg) Prasugrel Loading Dose in STEMI Patients: The Rapid Activity of Platelet Inhibitor Drugs (RAPID) Primary PCI 2 Study. 36
Diagnostic accuracy of 64-slice computed tomography coronary angiography for the detection of in-stent restenosis: a meta-analysis 36
Comparison of AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting With Direct Stenting Alone in Patients With Acute Myocardial Infarction: The JETSTENT Trial 36
Risk Stratification Using the CHA2DS2-VASc Score in Takotsubo Syndrome: Data From the Takotsubo Italian Network. 36
Comparison of effects of primary coronary angioplasty on left ventricular remodeling and heart failure in patients <70 versus > or =70 years with acute myocardial infarction 35
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. 35
Dual antiplatelet therapy in elderly patients with acute coronary syndrome: does age make the difference? 35
The concepts of rescue and facilitated percutaneous interventions in perspective 35
Pathophysiology of acute myocardial infarction 34
Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy. 34
Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic Study. 34
Transient left ventricular apical ballooning - The need for a common terminology 34
Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusional abnormalities in predischarge gated SPECT 34
Takotsubo is not a cardiomyopathy. 34
Combination of transfemoral balloon-assisted tracking and the knuckle wire technique as a solution in a challenging urgent percutaneous coronary intervention. 34
Interpretation of studies on the occurrence of atrial fibrillation in elite athletes. 34
Thrombus aspiration during myocardial infarction 33
Transient left bundle branch block and intraventricular dyssynchrony as a cause of reversibile left ventricular dysfunction. The “in vivo” documentation of spontaneous electrical remodeling. 33
Anterior mitral leaflet perforation and infective endocarditis following transcatheter aortic valve replacement in a patient presenting with heart failure 33
Totale 4.113
Categoria #
all - tutte 39.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.166 520 2 132 15 178 459 345 25 213 22 221 34
2020/20211.277 201 5 200 2 199 13 199 3 228 212 7 8
2021/2022867 169 4 3 4 2 2 7 70 73 28 94 411
2022/20231.590 219 94 47 278 109 264 0 187 267 6 70 49
2023/2024448 78 28 7 10 48 5 6 7 0 47 71 141
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 7.169